Gary Karlin

1.8k total citations
30 papers, 1.3k citations indexed

About

Gary Karlin is a scholar working on Pulmonary and Respiratory Medicine, Urology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gary Karlin has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Urology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gary Karlin's work include Sexual function and dysfunction studies (10 papers), Pediatric Urology and Nephrology Studies (9 papers) and Kidney Stones and Urolithiasis Treatments (8 papers). Gary Karlin is often cited by papers focused on Sexual function and dysfunction studies (10 papers), Pediatric Urology and Nephrology Studies (9 papers) and Kidney Stones and Urolithiasis Treatments (8 papers). Gary Karlin collaborates with scholars based in United States, United Kingdom and Germany. Gary Karlin's co-authors include Arthur D. Smith, Harin Padma-Nathan, Gopal Badlani, Thomas P. Segerson, Terry Taylor, Marc Gittelman, Wayne J.G. Hellstrom, Marc Thibonnier, Gerald Brock and Irwin Goldstein and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Mayo Clinic Proceedings.

In The Last Decade

Gary Karlin

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Karlin United States 16 809 555 356 323 316 30 1.3k
Evan R. Goldfischer United States 22 381 0.5× 272 0.5× 589 1.7× 134 0.4× 492 1.6× 64 1.4k
Lawrence C. Jenkins United States 19 663 0.8× 339 0.6× 383 1.1× 207 0.6× 203 0.6× 70 1.4k
RC Rosen United States 5 2.1k 2.6× 1.3k 2.3× 853 2.4× 634 2.0× 372 1.2× 6 2.7k
Steve Whitaker United States 7 566 0.7× 367 0.7× 181 0.5× 175 0.5× 57 0.2× 11 814
Antonino Saccà Italy 18 455 0.6× 221 0.4× 281 0.8× 112 0.3× 326 1.0× 57 1.0k
Andrew Gabrielson United States 17 486 0.6× 242 0.4× 225 0.6× 186 0.6× 103 0.3× 74 999
Marco Falcone Italy 21 701 0.9× 193 0.3× 494 1.4× 207 0.6× 180 0.6× 116 1.4k
Fred E. Govier United States 24 744 0.9× 307 0.6× 735 2.1× 245 0.8× 99 0.3× 68 1.9k
Serkan Deveci United States 15 498 0.6× 192 0.3× 183 0.5× 128 0.4× 204 0.6× 28 740
Martin Resnick United States 12 150 0.2× 164 0.3× 492 1.4× 72 0.2× 702 2.2× 18 1.3k

Countries citing papers authored by Gary Karlin

Since Specialization
Citations

This map shows the geographic impact of Gary Karlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Karlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Karlin more than expected).

Fields of papers citing papers by Gary Karlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Karlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Karlin. The network helps show where Gary Karlin may publish in the future.

Co-authorship network of co-authors of Gary Karlin

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Karlin. A scholar is included among the top collaborators of Gary Karlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Karlin. Gary Karlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldstein, Irwin, LeRoy Jones, Laurence Belkoff, et al.. (2012). Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men With Diabetes Mellitus. Mayo Clinic Proceedings. 87(9). 843–852. 68 indexed citations
2.
3.
Shore, Neal D., et al.. (2009). Phase III efficacy and safety trial of a new leuprolide acetate 3.75 mg depot formulation in prostate cancer patients. Journal of Clinical Oncology. 27(15_suppl). e16152–e16152. 1 indexed citations
4.
Steidle, Christopher P., et al.. (2007). 1177: Phase IIB Study of Bremelanotide in the Treatment of ED in Diabetic Males. The Journal of Urology. 177(4S). 388–388. 3 indexed citations
5.
Goldstein, Irwin, William A. Fisher, Michael Sand, et al.. (2005). Women's Sexual Function Improves When Partners are Administered Vardenafil for Erectile Dysfunction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Sexual Medicine. 2(6). 819–832. 120 indexed citations
6.
Giuliano, François, Craig F. Donatucci, Francesco Montorsi, et al.. (2004). Vardenafil is effective and well‐tolerated for treating erectile dysfunction in a broad population of men, irrespective of age. British Journal of Urology. 95(1). 110–116. 21 indexed citations
7.
8.
Brock, Gerald, Ajay Nehra, Larry I. Lipshultz, et al.. (2003). Safety and Efficacy of Vardenafil for the Treatment of Men With Erectile Dysfunction After Radical Retropubic Prostatectomy. The Journal of Urology. 170(4 Part 1). 1278–1283. 165 indexed citations
9.
Hellstrom, Wayne J.G., Marc Gittelman, Gary Karlin, et al.. (2002). Breakthroughs in Andrology Vardenafil for Treatment of Men With Erectile Dysfunction: Efficacy and Safety in a Randomized, Double-Blind, Placebo-Controlled Trial. 2 indexed citations
10.
Hellstrom, Wayne J.G., Marc Gittelman, Gary Karlin, et al.. (2002). Vardenafil for Treatment of Men With Erectile Dysfunction: Efficacy and Safety in a Randomized, Double‐Blind, Placebo‐Controlled Trial. Journal of Andrology. 23(6). 763–771. 239 indexed citations
11.
Karlin, Gary, et al.. (1992). Percutaneous pyeloplasty (endopyelotomy) for congenital ureteropelvic junction obstruction. Urology. 39(6). 533–537. 18 indexed citations
12.
Karlin, Gary & Arthur D. Smith. (1990). Greenberg Surgical Support System for the Endourologist. Urologic Clinics of North America. 17(1). 107–109. 1 indexed citations
13.
Karlin, Gary, et al.. (1990). Absence of Persisting Parenchymal Damage after Extracorporeal Shock Wave Lithotripsy as Judged by Excretion of Renal Tubular Enzymes. The Journal of Urology. 144(1). 13–14. 30 indexed citations
14.
Karlin, Gary, et al.. (1990). Benefits of an ultrasound-guided ESWL unit.. PubMed. 43(5). 579–81. 2 indexed citations
15.
Karlin, Gary, William Brock, Mark A. Rich, & Alberto Peña. (1989). Persistent Cloaca and Phallic Urethra. The Journal of Urology. 142(4). 1056–1059. 16 indexed citations
16.
Karlin, Gary & Arthur D. Smith. (1988). Endopyelotomy. Urologic Clinics of North America. 15(3). 439–444. 21 indexed citations
17.
Karlin, Gary, et al.. (1988). Nondilated Obstructive Uropathy. Journal of Endourology. 2(1). 35–39. 1 indexed citations
18.
Karlin, Gary, Gopal Badlani, & Arthur D. Smith. (1988). Endopyelotomy versus open pyeloplasty: comparison in 88 patients. The Journal of Urology. 140(3). 476–478. 112 indexed citations
19.
Karlin, Gary, Mark M. Rich, Won Lee, & Arthur D. Smith. (1987). Endourological Management of Upper-Tract Fungal Infection. Journal of Endourology. 1(1). 49–54. 4 indexed citations
20.
Smith, Arthur D., Robert Moldwin, & Gary Karlin. (1987). Percutaneous Ureterostomy. The Journal of Urology. 138(2). 286–288. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evan R. Goldfischer Breakdown of academic impact, for papers by Lawrence C. Jenkins Breakdown of academic impact, for papers by RC Rosen Breakdown of academic impact, for papers by Steve Whitaker Breakdown of academic impact, for papers by Antonino Saccà Breakdown of academic impact, for papers by Andrew Gabrielson Breakdown of academic impact, for papers by Marco Falcone Breakdown of academic impact, for papers by Fred E. Govier Breakdown of academic impact, for papers by Serkan Deveci Breakdown of academic impact, for papers by Martin Resnick
Rankless by CCL
2026